---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-083408"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2024-09-30T23:59:59+00:00"
generated_at: "2026-05-31T00:52:31.497851+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pasithea Therapeutics raises $5M in private placement of pre-funded warrants and Series A/B warrants

## Summary
- Gross proceeds ~$5M; net proceeds ~$4.5M after fees and expenses.
- Issued 1,219,513 pre-funded warrants at $0.001 exercise, plus Series A and B warrants at $3.85 exercise; combined price $4.099 per unit.
- Series A warrants expire in 5 years, Series B warrants expire in 18 months.
- Proceeds for working capital and general corporate purposes; H.C. Wainwright acted as placement agent.
- Company agreed to file resale registration statement within 15 days; 90-day lock-up on further equity issuance.

## SEC filing metadata
- accession: 0001213900-24-083408
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2024-09-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390024083408/0001213900-24-083408-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390024083408/ea0215863-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-083408
- JSON: https://secwatch.observer/filing/0001213900-24-083408.json
- Plain text: https://secwatch.observer/filing/0001213900-24-083408.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.